-
-
-
-
-
-
-
GE HealthCare (GEHC) Granted FDA Clearance for Portrait VSM
-
-
-
-
-
-
-
ZyVersa Therapeutics (ZVSA) Reports Publication Reinforcing the Rationale for Inhibiting ASC with IC 100 to Potentially Attenuate Cardiac Comorbidities
-
-
-
-
-
-
-
Labcorp (LH) Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
-
-
-
-
-
-
-
AstraZeneca (AZN) reports Enhertu's statistically significant and clinically meaningful improvement in progression-free survival in in DESTINY-Breast06 Phase III trial
-
-
-
-
-
-
-
Apellis' (APLS) Pegcetacoplan MAA Review Has Been Reset to Day 180 of Initial Assessment by EMA
-
-
-
-
-
-
-
AbbVie (ABBV): New Data Show RINVOQ Demonstrated Superiority Versus DUPIXENT Across Primary and All Secondary Endpoints
-
-
-
-
-
-
-
Gain Therapeutics (GANX) Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287
-
66,927 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.